OHCFF Financials: Light AI Inc AI Analysis

Home

Stock

OHCFF

Financials

OHCFF Financial

Light AI Inc

$0.05

-12.21%

$0

At close: Apr 02, 16:00:00 GMT-4

$0.05

Post-market: Apr 02, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Income

Balance sheet

Cash flow

Annual

Quarterly

OHCFF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	08/31/2024	08/31/2023	08/31/2022	08/31/2021
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	9	3	1	0	0	0
Research & Development	6	3	--	--	--	--
Operating Expenses	21	7	1	0	0	0
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-21	-13	-1	0	0	0
Income Tax Expense	--	--	--	--	--	--
Net Income	-21	-13	-1	0	0	0
Net Income Growth	--	1,200%	--	--	--	-100%
Shares Outstanding (Diluted)	118.98	13.05	7.4	2.56	10.24	1.32
Shares Change (YoY)	--	76%	189%	-75%	675%	11%
EPS (Diluted)	-0.18	-1	-0.15	-0.02	0	-0.14
EPS Growth	--	541%	482%	-891%	-102%	-97%
Free Cash Flow	-14	-6	0	0	0	0
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-21	-7	--	--	--	0
EBITDA Margin	0%	0%	--	--	--	0%
D&A For EBITDA	0	0	--	--	--	0
EBIT	-21	-7	-1	0	0	0
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Key Stats

Prev.Close

$0.0647

Open

$0.0542

Day's Range

$0.0542 - $0.0568

52 week range

$0.0375 - $0.52

Volume

342

Avg.Volume

85.3K

Dividend yield

EPS (TTM)

-0.08

Market Cap

$6.9M

What is LIGHT AI INC.?

Light AI Inc. is a technology company focused on developing artificial intelligence-based health screening and diagnostic solutions. The company is headquartered in Vancouver, British Columbia and currently employs 4 full-time employees. The company went IPO on 2025-01-08. The company is engaged in developing screening and diagnostic solutions aimed at improving healthcare delivery worldwide. The firm is developing a technology platform which represents the next generation of patient management that it applies AI algorithms to smartphone images, starting with images of Strep A and anticipated expansion with COVID19 along with other medical conditions, to identify the disease in seconds. Its app-based solution requires no swabs, lab tests or proprietary hardware of any kind. Its AI powered technology offers screening and diagnostic tools designed to address critical healthcare challenges. Its technology offers a significant advancement in the identification of GAS pharyngitis. Its approach to applying AI to smartphone images can be expanded to other throat conditions, as well as other areas of analysis, such as the human eye and skin.



Features

AI Copilot for Stock & Crypto

Resources